This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hedrin lotion (4% dimeticone in a silicone solvent)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Hedrin lotion (4% dimeticone in a silicone solvent)

  • is a topical treatment for head lice
  • is a colourless and odourless liquid - it has a slightly oily texture - that is applied to the hair
  • it is left to dry and washed off after at least 8 hours
  • it is important that the scalp and all the hair are wetted with the fluid (including the full length of long hair)
  • two applications of treatment, 7 days apart, are recommended - this is in order to kill nymphal lice emerging from eggs which might not have been killed by the first application
  • mode of action
    • the dimeticone in its silicone solvent is believed to immobilse the lice once they become covered in the preparation. As the solvent evaporates the lice are then left coated by a layer of dimeticone - it is believed that the lice die by reverse osmotic effects caused by a disruption of their ability to manage internal water
    • no evidence that lice can become resistant to dimeticone
  • a review concluded that ".. it seems reasonable to regard dimeticone as a first-line alternative to malathion, permethrin or phenothrin, particularly for parents or patients who do not wish to use conventional insecticides..."

Reference:

  1. Drug and Therapeutics Bulletin (2007); 45(7):52-5.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.